Literature DB >> 30508781

Disease-specific attention impairment in disorders of chronic excessive daytime sleepiness.

Markus Ramm1, Matthias Boentert1, Nelly Lojewsky1, Arsalan Jafarpour2, Peter Young1, Anna Heidbreder3.   

Abstract

OBJECTIVE: Patients with chronic excessive daytime sleepiness (EDS) complain of substantial attention deficits. However, their underlying neuronal dysfunction is largely unknown. Previous studies showed similar attention performances in central disorders of hypersomnolence suggesting that EDS-related cognitive impairment is independent of its cause. The aim of the current study was to further explore attentional profiles in disorders of chronic EDS.
METHODS: Ten patients with narcolepsy type 1 (NT1; age 26.7 ± 9.3 years), 14 patients with idiopathic hypersomnia (IH; age 26.7 ± 9.3 years), 14 patients with subjective EDS (sEDS; age 31.4 ± 14.3 years), ie, a mean sleep latency >8 min in the multiple sleep latency test (MSLT), and 20 healthy controls (HC; age 32.6 ± 11.3 years) performed the vigilance task and the selective attention task of the test battery SLEEP® (Vienna Test System Neuro®). We assessed mean response time (RT) and standard deviation of RT separately for the first and the second half of the vigilance task to evaluate performance changes over time (time on task effect; TOT).
RESULTS: A significant interaction effect between group and TOT on the mean RT in the vigilance task suggests partly group-specific attention deficits. Combining paradigms of sustained and selective attention discriminated patients with NT1, IH, sEDS and HC. Behavioral results were unrelated to the mean sleep latency in the MSLT.
CONCLUSIONS: Discriminative performance of the sustained and selective attention tasks indicate disease-specific components of attention in NT1, IH, and sEDS. Different temporal dynamics of attentional control efficiency might be one factor underlying group differences.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Attention; Cognition; Excessive daytime sleepiness; Idiopathic hypersomnia; Narcolepsy

Mesh:

Year:  2018        PMID: 30508781     DOI: 10.1016/j.sleep.2018.09.021

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  5 in total

1.  Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registry.

Authors:  Lynn Marie Trotti; Jason C Ong; David T Plante; Catherine Friederich Murray; Rebecca King; Donald L Bliwise
Journal:  Sleep Med       Date:  2020-09-02       Impact factor: 3.492

2.  Twice is nice? Test-retest reliability of the Multiple Sleep Latency Test in the central disorders of hypersomnolence.

Authors:  Lynn Marie Trotti
Journal:  J Clin Sleep Med       Date:  2020-12-17       Impact factor: 4.062

Review 3.  Idiopathic Hypersomnia and Other Hypersomnia Syndromes.

Authors:  Lynn Marie Trotti; Isabelle Arnulf
Journal:  Neurotherapeutics       Date:  2021-01       Impact factor: 7.620

4.  Self-reported symptoms and objective measures in idiopathic hypersomnia and hypersomnia associated with psychiatric disorders: a prospective cross-sectional study.

Authors:  Jitka Bušková; Tomáš Novák; Eva Miletínová; Radana Králová; Jana Košt Álová; Monika Kliková; Karolina Veldová
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

5.  Sleep and Psychosocial Characteristics of Children with Narcolepsy According to Their Intellectual Profile: A Case-Control Study.

Authors:  Marine Thieux; Min Zhang; Agathe Marcastel; Alice Poitrinal; Fanny Vassias; Aurore Guyon; Olivier Revol; Stephanie Mazza; Anne Guignard-Perret; Patricia Franco
Journal:  J Clin Med       Date:  2022-08-10       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.